1 / 22

PROVOCARE DIAGNOSTICA – CE POATE ASCUNDE gRANULOMATOZA

PROVOCARE DIAGNOSTICA – CE POATE ASCUNDE gRANULOMATOZA. Sectia Medicala II Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila Medic rezident , Oana Stancu , anul I. Anamneza. 61 ani, bărbat

rachel
Télécharger la présentation

PROVOCARE DIAGNOSTICA – CE POATE ASCUNDE gRANULOMATOZA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PROVOCARE DIAGNOSTICA – CE POATE ASCUNDE gRANULOMATOZA Sectia Medicala II Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila Medic rezident, Oana Stancu, anul I

  2. Anamneza • 61 ani, bărbat • INTERNARE 2012 : fatigabilitate, astenie, dispnee, scădere ponderala aproximativ 10kg in 2-3 luni. • APP: -hiperuricemie, guta cronica tofacee, nefropatie urica -diabet zaharat tip II echilibrat cu ADO -dislipidemie • tratament cronic alopurinol, rosuvastatin, ADO (diaprel).

  3. Examenul clinic • deformarearticulatiilormicimainisipicioare • tofigutosivoluminosicoatesipicioare • ficat cu margineainferioara 4 cm sub rebord, rotunjita, consistentacrescuta

  4. Date biologice • Sindrom biologic inflamator VSH 51mm/h ( <10mm/h), CRP 24mg/dl ( <6mg/dl), fibrinogen 920 mg/dl ( 183-383 mg/dl). • Hiperuricemiesiretentieazotata ac. uric 11.5g/dl ( 2,6-7,2 g/dl), creatinina 1.5 mg/dl ( 0,6-1,3 mg/dl). • Glicemie135 mg/dl( 74-106mg/dl), HbA1c 6.8 Sindrom de colestazasicitoliza hepatica GGT 425 ui/ml ( 5-85ui/l), ALP 311ui/l (50-136ui/l), TGO 94 ui/l (15-37ui/l), TGP 311 ui/l ( 30-65ui/l). Markerivirali ( AgHbs, AC.anti VHC)- negativi

  5. Ecografieabdominala • Ficat cu dimensiunicrescute, structuradifuzsiintens neomogena, colecist cu pereteingrosat , aspect edematiat , cu imagini de calculi; RD cu structuracompletremaniata cu stergerea conturuluidintrecorticalasimedulara.

  6. ExplorariparacliniceRx cord pulmon • hiluricu arie de proiectiemarita; conturpoliciclic; posibilecalcificari in interior; desen interstitial accentuat. • opacitatimicronodularesinodulare , parahilardreaptasistanga .

  7. CT TORACE Micronodulisinoduli cu dimens. maxime 1 cm localizati in segm ventral LSD siparahilar Adenopatiimediastinaleparatraheale, infracarinale, intertraheobronsicedreptedimens.max 2/1,4 cm. CT abdominal : ficat cu dimensiunimultcrescutesimiciadenopatii in pediculul hepatic

  8. Bronhoscopie laringe cu dinamicaprezenta; coardavocalastanga la polul posterior cu buchet de granuloame ulcerate; arborelebronsic bilateral cu aspect bronsitic, peteantracotice, faraaspecte proliferative; Aspiratbronsic– BK absent in frotiu direct; culturi BK – in lucru; LBA - limfocitoza cu CD4/CD8multcrescut.

  9. Biopsie hepatica Fragmentebiopsice de tesut hepatic cu arhitecturalobularaconservata, prezentandfibrozasiinfiltratinflamatoralcatiut din limfocite predominant si din rare eozinofile la nivelulspatiilorporte, faraprezenta de leziuni ale ductelor; se gasescdeasemeneasigranuloameepiteloidegigantocelulare, faraprezenta de necroza de cazeificare , atat la nivelulspatiilorporte cat siintralobular, sugerandinflamatiegranulomatoasasarcoidozica.

  10. Date suplimentare • S-a determinatenzima de conversie a angiotensinei 102 u/l (N 12-68). • Examenoftalmologicsi dermatologic- faraparticularitati. • Avand in vedereprezentagranulomului hepatic sarcoidozicsiaspectul LBA, celmaiprobabilafectareapulmonara are aceeasietiologie. • Polip de coardavocalaexcizat-polipangioedematosasociate cu fragmente de mucoasaacoperite de epiteliuscuamospapilomatos, marcathiperkeratozic, moderatdisplazic

  11. Diagnostic • 1. Sarcoidoza hepatica sipulmonara • 2. Hiperuricemie. Gutacronicatofacee. Nefropatieuricainterstitiala. Boalacronica de rinichi • 3. Diabetzaharat tip II echilibrat cu ADO • 4. Formatiunetumoralacoardavocalastanga.

  12. Tratament • Prednison40 mg /zi ( 0,5mg/kgc) • Milurit 100 mg 1cp/zi • Diaprelmr 35 mg 2cp/zi 1 luna • Evolutie cu ameliorareclinicasemnificativainvolutiahepatomegalieisi a sindromului de colestaza

  13. BK prezent in culturi , dupa 2 luni TUBERCULOZAPULMONARA

  14. Internareftiziologiemai 2012 se instituietratament H300R600Z2000E1600 7/7

  15. Evenimenteleulterioare • NOIEMBRIE 2013 - Reevaluarepneumologie: • Bronhoscopiecu LBA siaspiratbronsic: citologienormala, flora farasemnificatiepatogenica, BK absent in frotiudirect; • BK in culturi - in lucru; • - CT toracic- faramodificaripatologice. • - Biologic: usoaracolestazasicitolizahepatia (TGO 65ui/l; TGP 105ui/l; GGT 160ui/l; ALP 186ui/l • IANUARIE 2014: Medicala II • Hepatomegalie cu consistentacrescuta; TGO 128 ui/l ( 15-37ui/l), TGP 136 ui/l ( 30-65ui/l), GGT 621 ui/l ( 5-85ui/l); ALP 558ui/l (50-136ui/l); • Eco abdomen: faradilatatie de CBP si CBIH; aspect neomogen • S-a repetatbiopsia hepatica- aspect similar anterioara; • Reluareacorticoterapiei- Prednison 40 mg/zi ( 0,5mg/kgc) cu scadereatreptata a dozei. • -evolutieclinicasiparaclinicasatisfacatoare la 4 luni.

  16. Diagnostic final • 1. Sarcoidoza hepatica sipulmonara • 2. Tuberculozapulmonara • 3. Hiperuricemie. Gutacronicatofacee. Nefropatieuricainterstitiala. Boalacronica de rinichi • 4. Diabetzaharat tip II echilibrat cu ADO • 5. Formatiunetumoralacoardavocalastanga.

  17. Discutii • Prezentaconcomitenta a celordouapatologii la acelasipacient- RARA (putinecazuri in literatura). • Provocarediagnostica: proceduridiagnosticesimilare • Capcanapentruclinicieni- prezentauneia nu poate exclude existentaceleilalte. • Gandiremedicalasiconduitaterapeuticaampla in fata unuiastfel de caz

  18. Vamultumesc!

  19. Examen radiologic Rx maini Cresterea intensitatiitesuturilormoiadiacente art metacarpofalangianadeget II-III manastanga, epifizadistalametacarpian II cu structuraosoasademineralizatasicontursters. Rx bazinsiarticulatiisacroiliace Coxartrozaavansata bilateral osteocondensareversantiososarticulatiisacroiliace

More Related